For help on how to get the results you want, see our search tips.
2 results
Medicine type
Additional monitoring Remove Additional monitoring filter
Orphan medicine Remove Orphan medicine filter
Conditional approval Remove Conditional approval filter
Generic Remove Generic filter
Medicine
Orphan designations Remove Orphan designations filter
Referrals Remove Referrals filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Referral status
Procedure started Remove Procedure started filter
-
List item
Referral: Rubraca (updated)
rucaparib, associated names: Rubraca, Article 20 procedures
Status: Procedure started, Last updated: 06/05/2022 -
List item
Referral: Janus Kinase inhibitors (JAKi)
tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Procedure started, Last updated: 11/02/2022